Connect With Us

“Hot news, cold truths, utterly uncensored.” —Greg Palast
“[Censored] offers devastating evidence of the dumbing-down of main-stream news in America. . . . Required reading for broadcasters, journalists, and well-informed citizens.” —Los Angeles Times
“Project Censored continues to be an invaluable resource in exposing and highlighting shocking stories that are routinely minimized or ignored by the corporate media. The vital nature of this work is underscored by this year’s NSA leaks. The world needs more brave whistle blowers and independent journalists in the service of reclaiming democracy and challenging the abuse of power. Project Censored stands out for its commitment to such work.” —Deepa Kumar, author of Islamophobia and the Politics of Empire and associate professor of Media Studies and Middle Eastern Studies at Rutgers University
“For ages, I’ve dreamed of a United States where Project Censored isn’t necessary, where these crucial stories and defining issues are on the front page of the New York Times, the cover of Time, and in heavy rotation on CNN. That world still doesn’t exist, but we always have Project Censored’s yearly book to pull together the most important things the corporate media ignored, missed, or botched.” –Russ Kick, author of You Are Being Lied To, Everything You Know Is Wrong, and the New York Times bestselling series The Graphic Canon.
“In another home run for Project Censored, Censored 2013 shows how the American public has been bamboozled, snookered, and dumbed down by the corporate media. It is chock-full of ‘ah-ha’ moments where we understand just how we’ve been fleeced by banksters, stripped of our civil liberties, and blindly led down a path of never-ending war.” –Medea Benjamin, author of Drone Warfare, cofounder of Global Exchange and CODEPINK.
“Project Censored shines a spotlight on news that an informed public must have . . . a vital contribution to our democratic process.” —Rhoda H. Karpatkin, president, Consumer’s Union
“Most journalists in the United States believe the press here is free. That grand illusion only helps obscure the fact that, by and large, the US corporate press does not report what’s really going on, while tuning out, or laughing off, all those who try to do just that. Americans–now more than ever–need those outlets that do labor to report some truth. Project Censored is not just among the bravest, smartest, and most rigorous of those outlets, but the only one that’s wholly focused on those stories that the corporate press ignores, downplays, and/or distorts. This latest book is therefore a must read for anyone who cares about this country, its tottering economy, and–most important– what’s now left of its democracy.” –Mark Crispin Miller, author, professor of media ecology, New York University.
“Project Censored brings to light some of the most important stories of the year that you never saw or heard about. This is your chance to find out what got buried.” –Diane Ravitch, author of The Death and Life of the Great American School System.
“Activist groups like Project Censored . . . are helping to build the media democracy movement. We have to challenge the powers that be and rebuild media from the bottom up.” —Amy Goodman
“The staff of Project Censored presents their annual compilation of the previous year’s 25 stories most overlooked by the mainstream media along with essays about censorship and its consequences. The stories include an 813% rise in hate and anti-government groups since 2008, human rights violations by the US Border Patrol, and Israeli doctors injecting Ethiopian immigrants with birth control without their consent. Other stories focus on the environment, like the effects of fracking and Monsantos GMO seeds. The writers point out misinformation and outright deception in the media, including CNN relegating factual accounts to the “opinion” section and the whitewashing of Margaret Thatcher’s career following her death in 2013, unlike Hugo Chavez, who was routinely disparaged in the coverage following his death. One essay deals with the proliferation of “Junk Food News,” in which “CNN and Fox News devoted more time to ‘Gangnam Style’ than the renewal of Uganda’s ‘Kill the Gays’ law.” Another explains common media manipulation tactics and outlines practices to becoming a more engaged, free-thinking news consumer or even citizen journalist. Rob Williams remarks on Hollywood’s “deep and abiding role as a popular propaganda provider” via Argo and Zero Dark Thirty. An expose on working conditions in Chinese Apple factories is brutal yet essential reading. This book is evident of Project Censored’s profoundly important work in educating readers on current events and the skills needed to be a critical thinker.” -Publisher’s Weekly said about Censored 2014 (Oct.)
“One of the most significant media research projects in the country.” —I. F. Stone
“Censored 2014 is a clarion call for truth telling. Not only does this volume highlight fearless speech in fateful times, it connect the dots between the key issues we face, lauds our whistleblowers and amplifies their voices, and shines light in the dark places of our government that most need exposure.” –Daniel Ellsberg, The Pentagon Papers
“Project Censored interrogates the present in the same way that Oliver Stone and I tried to interrogate the past in our Untold History of the United States. It not only shines a penetrating light on the American Empire and all its deadly, destructive, and deceitful actions, it does so at a time when the Obama administration is mounting a fierce effort to silence truth-tellers and whistleblowers. Project Censored provides the kind of fearless and honest journalism we so desperately need in these dangerous times.” —Peter Kuznick, professor of history, American University, and coauthor, with Oliver Stone, of The Untold History of the United States
Buy it, read it, act on it. Our future depends on the knowledge this col-lection of suppressed stories allows us.” —San Diego Review
“[Censored] should be affixed to the bulletin boards in every newsroom in America. And, perhaps read aloud to a few publishers and television executives.” —Ralph Nader
“Those who read and support Project Censored are in the know.” —Cynthia McKinney
“At a time when the need for independent journalism and for media outlets unaffiliated with and untainted by the government and corporate sponsors is greater than ever, Project Censored has created a context for reporting the complete truths in all matters that matter. . . . It is therefore left to us to find sources for information we can trust. . . . It is in this task that we are fortunate to have an ally like Project Cen-sored.” —Dahr Jamail
“Project Censored is one of the organizations that we should listen to, to be assured that our newspapers and our broadcasting outlets are practicing thorough and ethical journalism.” —Walter Cronkite

24. Profits-Before-People Delays Release New AIDS Drug

Sources: SAN FRANCISCO BAY TIMES Title: “The Fight For 1592: AIDS Activists Battle Glaxo Over Access To Anxiously Awaited New Drug,” Date: May 15, 1997 Author: Bruce Mirken; SAN FRANCISCO BAY GUARDIAN Title: “OTC Drugs to be Boycotted: AIDS Activists Announce Boycott of Drug Company,” Date: July 2, 1997 Author: Nina Siegal

Major media coverage: The Wall Street Journal, November 12, 1996, section B, page 1, column 3

SSU Censored Researchers: Kecia Kaiser, Deborah Udal, and Bryan Way
Community Evaluator: Mary King, M.D.

A decade after the high price of AZT caused AIDS activists to declare a war on Burroughs Wellcome pharmaceutical company, the AIDS community is again gearing up for battle with drug giant Glaxo-Wellcome over access to what San Francisco AIDS Foundation Director of Treatment Education and Advocacy Ron Baker calls “the most important AIDS drug in the research pipeline.”

That drug, known as 1592U89, or 1592, belongs to the class of drugs called nucleoside analogs, (a.k.a. “nukes”) the same category as AZT, 3TC, ddC, ddl, and d4T. For full effectiveness, nukes must be, “cocktailed,” or combined with other protease and non-protease inhibitor drugs. Many AIDS patients have already used the older nukes and have HIV strains that have become resistant to these drugs. For them, 1592, which in earlier tests demonstrated far more anti-HIV punch and appears to be less toxic, represents the only hope for building a drug cocktail that can keep them alive.

Realizing the need for 1592, advocates began meeting with Glaxo-Wellcome last summer to persuade the company to offer the drug immediately on a “compassionate use” basis. Glaxo said they would consider it, but unveiled a plan with only three minuscule programs—one for children, one for those suffering from severe dementia, and a third for adults without dementia—which would enroll a total of 2,500 patients. Equally alarming is the fact that access will be restricted to only 30 to 50 sites worldwide. Adults will have to enroll at unspecified “geographically dispersed centers”—which is also unusual.

The company doesn’t expect to file for FDA approval until mid-1998 because of concerns that there is a serious lack of general information on its effects, and because studies have included so few people. Glaxo claims that it is a lack of knowledge around the specifics of how viral resistance works that is holding up their filing for FDA approval.

AIDS activists aren’t buying Glaxo’s assertions. The 1592 Access Coalition says Glaxo-Wellcome has been stalling development of the drug for nine years because it already manufactures most of the current AIDS medications available. Since these provide a large share of Glaxo’s profits, 1592 may make the older drugs become very unpopular, even extinct. Many believe Glaxo is stalling to maximize profits from current AIDS drugs. In other words, profits stand in the way of millions of desperate and dying people.

UPDATE BY AUTHOR BRUCE MIRKEN: “This article was written after nearly a year of glowing media stories that all but declared AIDS over as a result of new anti-HIV drugs that became widely available in 1996. Doctors, researchers, and AIDS activists knew that the drugs weren’t working for everyone and that access to promising new compounds was becoming a critical issue for thousands who were running out of options, but little of this was being reported. This story is significant because it represented the tip of a much larger iceberg: That the much-heralded protease inhibitors, though important, were not a miracle cure and that the pharmaceutical industry’s responsibilities to people with AIDS had not ended.

“I must add that Project Censored’s decision to recognize this piece is significant in another, equally important way. Project Censored has had a long and unhappy history of paying little attention to the gay and lesbian press, for which it has been taken to task repeatedly. I fervently hope this means we’re finally on the radar screen for good.

“The campaign for access to 1592 continued through the summer, with a series of protests staged by ACT UP/New York, ACT UP/Golden Gate (based in San Francisco), and others. Over a dozen organizations united to call for an international boycott on Zantac, Glaxo’s top-selling product. For months there was little progress, but in October 1997, the company agreed to make the drug available on a larger scale in early 1998, in a program with fewer restrictions, and some activists considered the company’s offer good enough to allow them to call off the boycott.

“I am not aware of any mainstream press response to my story, but the protests organized by ACT UP did attract some mainstream media attention beginning in June and July. In San Francisco both daily papers and some radio and TV stations did stories on 1592 and the boycott of Glaxo.”

For more information on this and related AIDS-treatment access and research issues, some good places to start are:

ACT UP/Golden Gate, Tel: 415/252-2900;
Web site:;

ACT UP/East Bay, Tel: 510/568-1680;

ACT UP/New York, Tel: 212/966-4813;
Web site:;

Project Inform, Tel: 415/558-8669; AIDS Treatment News, Tel: 800/ TREAT12 (for subscription information).

UPDATE BY AUTHOR NINA SIEGAL: “In addition to the boycott of Glaxo-Wellcome by the San Francisco chapter of AIDS activist group ACT UP/Golden Gate, Mothers’ Voices, a group of mothers of people with AIDS or otherwise related to people who had died from AIDS, then urged the heads of two New York State public employee retirement systems to divest from Glaxo-Wellcome. The two investment funds sent letters to Glaxo threatening to pull out a million shares, worth more than $50 million, if the company did not expand its compassionate use program.

“As a result of the pressure exerted by a four-month boycott, on October 13, the company met with ACT UP to discuss the group’s demands, and on October 31, the company agreed to implement an expanded drug access program with no limits. The only criteria would be that the patient be unable to put together a triple combination therapy program.

“The announcement of the boycott was covered in San Francisco by the local gay newspapers and was later picked up by the Associated Press. But according to John Iversen, co-founder of ACT UP/East Bay, the AP story only ran in the San Francisco Examiner. The threat of divestment was covered by The New York Post on August 8, but that story received no other press attention, according to Iverson. To publicize the boycott, ACT UP brought advertisements in The Nation and In These Times, but neither of those publications ran a story on the boycott.”

Facebook Comments